These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33207174)

  • 21. Emergency department interventions for opioid use disorder: A synthesis of emerging models.
    Thomas CP; Stewart MT; Tschampl C; Sennaar K; Schwartz D; Dey J
    J Subst Abuse Treat; 2022 Oct; 141():108837. PubMed ID: 35841743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Treatment of Opioid Withdrawal and Opioid Use Disorder in the Emergency Department.
    Jennings L; Warner T; Bacro-Duverger B
    MedEdPORTAL; 2020 May; 16():10899. PubMed ID: 32656320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.
    Im DD; Chary A; Condella AL; Vongsachang H; Carlson LC; Vogel L; Martin A; Kunzler N; Weiner SG; Samuels-Kalow M
    West J Emerg Med; 2020 Feb; 21(2):261-271. PubMed ID: 32191184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study.
    Heil J; Ganetsky VS; Salzman MS; Hunter K; Baston KE; Carroll G; Ketcham E; Haroz R
    West J Emerg Med; 2022 Apr; 23(3):386-395. PubMed ID: 35679506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.
    Holland WC; Nath B; Li F; Maciejewski K; Paek H; Dziura J; Rajeevan H; Lu CC; Katsovich L; D'Onofrio G; Melnick ER
    Acad Emerg Med; 2020 Aug; 27(8):753-763. PubMed ID: 32352206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of an emergency department peer navigator (EDPN) program in improving clinical outcomes and healthcare utilization in an urban setting.
    Santos C; Ramdin C; Becceril J; Al Kik B; Jefri M; Nelson L
    Am J Emerg Med; 2023 Jun; 68():10-16. PubMed ID: 36905880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.
    Hu T; Snider-Adler M; Nijmeh L; Pyle A
    CJEM; 2019 Jul; 21(4):492-498. PubMed ID: 31006398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine/naloxone initiation and referral as a quality improvement intervention for patients who live with opioid use disorder: quantitative evaluation of provincial spread to 107 rural and urban Alberta emergency departments.
    Stone KD; Scott K; Holroyd BR; Lang E; Yee K; Taghizadeh N; Deol J; Dong K; Fanaeian J; Ghosh M; Low K; Ross M; Tanguay R; Faris P; Day N; McLane P
    CJEM; 2023 Jul; 25(7):598-607. PubMed ID: 37245202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of buprenorphine for opioid use disorder in the hospital setting: Practice models, challenges, and legal considerations.
    Mospan GA; Chaplin M
    Am J Health Syst Pharm; 2022 Jan; 79(3):140-146. PubMed ID: 34554207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments.
    Kumar P; Kaliamurthy S; Thomas J
    Pediatrics; 2024 Aug; 154(2):. PubMed ID: 38966873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linking MATTERS: Barriers and Facilitators to Implementing Emergency Department-Initiated Buprenorphine-Naloxone in Patients with Opioid Use Disorder and Linkage to Long-Term Care.
    Sokol R; Tammaro E; Kim JY; Stopka TJ
    Subst Use Misuse; 2021; 56(7):1045-1053. PubMed ID: 33825669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department.
    Hawk K; Hoppe J; Ketcham E; LaPietra A; Moulin A; Nelson L; Schwarz E; Shahid S; Stader D; Wilson MP; D'Onofrio G
    Ann Emerg Med; 2021 Sep; 78(3):434-442. PubMed ID: 34172303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
    D'Onofrio G; Chawarski MC; O'Connor PG; Pantalon MV; Busch SH; Owens PH; Hawk K; Bernstein SL; Fiellin DA
    J Gen Intern Med; 2017 Jun; 32(6):660-666. PubMed ID: 28194688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study.
    McCormack RP; Rotrosen J; Gauthier P; D'Onofrio G; Fiellin DA; Marsch LA; Novo P; Liu D; Edelman EJ; Farkas S; Matthews AG; Mulatya C; Salazar D; Wolff J; Knight R; Goodman W; Hawk K
    Addict Sci Clin Pract; 2021 Mar; 16(1):16. PubMed ID: 33750454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.
    Fox L; Nelson LS
    CNS Drugs; 2019 Dec; 33(12):1147-1154. PubMed ID: 31552608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A qualitative assessment of emergency physicians' experiences with robust emergency department buprenorphine bridge programs.
    Heil JM; Lassiter JM; Salzman MS; Herring A; Hoppe J; Lynch M; Weiner SG; Roberts B; Haroz R
    Acad Emerg Med; 2024 Jun; 31(6):576-583. PubMed ID: 38357749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment retention of an emergency department initiated medication for opioid use disorder program.
    Reuter QR; Santos AD; McKinnon J; Gothard D; Jouriles N; Seaberg D
    Am J Emerg Med; 2022 May; 55():98-102. PubMed ID: 35304308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals.
    Patel E; Solomon K; Saleem H; Saloner B; Pugh T; Hulsey E; Leontsini E
    J Subst Abuse Treat; 2022 May; 136():108658. PubMed ID: 34774397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers and facilitators associated with establishment of emergency department-initiated buprenorphine for opioid use disorder in rural Maine.
    Rosenberg NK; Hill AB; Johnsky L; Wiegn D; Merchant RC
    J Rural Health; 2022 Jun; 38(3):612-619. PubMed ID: 34468047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiences with an addiction consultation service on care provided to hospitalized patients with opioid use disorder: a qualitative study of hospitalists, nurses, pharmacists, and social workers.
    Callister C; Lockhart S; Holtrop JS; Hoover K; Calcaterra SL
    Subst Abus; 2022; 43(1):615-622. PubMed ID: 34666634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.